Member Exclusive News

The week in industry: Cell-based influenza vaccine nears European approval

This week: Seqirus’ cell-based influenza vaccine nears European approval and KemPharm announces collaboration with twoXAR to develop prodrug-based therapies for multiple indications.

Thumb untitled design
Oct 25, 2018
0
0

Please sign in or register for FREE

No comments yet.